ST Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Gains ADNT Q1 2026 Earnings EPS Surpasses Estimates by 172 on Strong Operational Execution DTIL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Advances Pipeline COCH Q1 2026 Earnings EPS Beats Estimates Despite PreRevenue Status Stock Declines WTBA Q1 2026 Earnings EPS Beat Surprises Stock Declines Evaxion Q1 2026 Earnings EPS Miss Weighs on PreRevenue Biotech Stock Edges Higher